Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders

Novo Nordisk's CEO said the complexities of the U.S. healtchare system prevented access to $1,349 Wegovy.

Tomas K - Moderator Tomas K - Moderator
Sep 24, 2024 - 14:00
Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
Novo Nordisk's CEO said the complexities of the U.S. healtchare system prevented access to $1,349 Wegovy. Read More
Read More